Jin Medical International Ltd.
Jin Medical International Ltd. designs, manufactures and sells rehabilitation medical equipment, centered on wheelchairs and living aids for people with disabilities, older adults, and rehabilitation users. The company is headquartered in Changzhou, Jiangsu Province, China and operates manufacturing facilities in China while distributing products domestically and through overseas distributors.
Fiscal year 2025 · change from previous year
Development 2021–2025
Business
Share of revenueManual and rehabilitation wheelchairs sold through domestic and international distributors.
Daily living and mobility support products for disabled and elderly users.
Products
Reported · share of revenue- Wheelchair78.4 %
- Other Products12.5 %
- Wheelchair Components9.1 %
Source: 20-F FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
The company sells primarily to distributors that supply rehabilitation and mobility products in China and export markets, especially Japan. End users include people with disabilities, elderly individuals, and patients needing rehabilitation support, but the company’s commercial customers are mainly distributors rather than direct consumers. Its product mix and model count suggest demand from institutional resellers that need a broad catalog for mobility and care applications.
Buy wheelchairs and living aids for domestic resale across rehabilitation and elder-care channels.
Buy the majority of wheelchair models for resale in Japan's mobility aid market.
Buy selected products for resale in overseas rehabilitation and mobility markets.
Use the products for mobility assistance, disability support, and rehabilitation.
Strategy
The company is focused on broadening its rehabilitation product portfolio, maintaining lightweight and ergonomic design capability, and expanding manufacturing capacity in China. It also emphasizes supply chain diversification, regional manufacturing flexibility, and compliance across markets to support overseas distribution and manage geopolitical exposure.
A broader and better-designed product line supports distributor demand and helps defend share in mobility equipment.
Additional capacity supports growth, operational flexibility, and supply reliability for domestic and export orders.
The business relies on distributors to reach end markets efficiently in China and overseas.
Cross-border sourcing and sales create exposure to policy and logistics disruptions.
Geography
Jin Medical is based in Changzhou, China and manufactures in Jiangsu and Anhui provinces. The business is concentrated in China and Japan, with additional sales through more than 20 international distributors; the company also notes that the majority of wheelchair products are sold to distributors in Japan and China.
Risks
Jin Medical depends heavily on distributor channels and on demand for rehabilitation and mobility products in China, Japan, and export markets, so channel concentration or end-market softness could affect sales. The company also faces manufacturing, regulatory, and geopolitical risks typical of cross-border industrial producers, including U.S.-China policy shifts, supply chain interruptions, and compliance requirements in multiple markets.
- Distributor concentrationImpact: HighLikelihood: High
The company sells mainly through distributors, with major exposure to China and Japan channels.
Exposure: China and Japan distributors
- Geopolitical and trade riskImpact: HighLikelihood: Medium
Management explicitly notes U.S.-China relations and the need for supply chain diversification.
Exposure: Cross-border manufacturing and exports
- Foreign exchange volatilityImpact: MediumLikelihood: High
The company reports foreign currency translation gains and losses, indicating FX sensitivity.
Exposure: Renminbi and overseas reporting currency effects
- Manufacturing execution riskImpact: MediumLikelihood: Medium
New facilities and multi-plant operations require scale-up discipline and consistent quality control.
Exposure - Regulatory compliance riskImpact: MediumLikelihood: Medium
Medical mobility products require compliance across different markets and standards.
Exposure: Product certifications and market access
Accounting
Judgemental itemsThe company manages as one reportable segment, so analysis depends on consolidated cost and margin trends.
Impact: Reduces external visibility into product or regional profitability
Revenue is broken out by product types and geographic areas in the notes.
Impact: Important for understanding mix and regional dependence
The company reports translation gains and losses in comprehensive income.
Impact: Can materially affect equity and total comprehensive income
New facilities and existing plants require judgment around capitalization and useful lives.
Impact: Affects depreciation and balance sheet asset values
Similar listed companies
Publicly listed companies with a comparable business focus.
Kun Peng International Ltd.
KPEA · Services-Educational Services
Yunji Inc.
YJ · Retail-Retail Stores, NEC
Bon Natural Life Ltd
BON · Medicinal Chemicals & Botanical Products
Bon Natural Life Ltd develops, manufactures, and commercializes natural active ingredients for health, functional food, and personal care applications.
IR-Med, Inc.
Electromedical & Electrotherapeutic Apparatus
Concord Medical Services Holdings Ltd
CCM · Services-Offices & Clinics of Doctors of Medicine
Concord Medical Services Holdings Ltd is a medical services group headquartered in Beijing, with operations centered on hospital, clinic, and other healthcare service assets in China.
China SXT Pharmaceuticals, Inc.
SXTC · Pharmaceutical Preparations
Last updated: 28/09/2026